Rani Therapeutics Inc. (RANI)
1.31
0.03 (2.34%)
At close: Jan 15, 2025, 3:59 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 5.86M | 27.01M | 117.45M | 73.06M | 16.54M |
| Short-Term Investments | 42.67M | 71.47M | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | 1.63M |
| Other Long-Term Assets | 246.00K | n/a | n/a | n/a | n/a |
| Receivables | n/a | n/a | n/a | 1.72M | 250.00K |
| Inventory | n/a | n/a | n/a | n/a | 1.00 |
| Other Current Assets | 2.31M | 2.44M | 2.14M | 167.00K | 158.00K |
| Total Current Assets | 50.85M | 100.92M | 119.59M | 74.94M | 16.94M |
| Property-Plant & Equipment | 6.82M | 7.10M | 4.61M | 4.47M | 4.45M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 7.07M | 7.10M | 4.61M | 4.47M | 6.08M |
| Total Assets | 57.92M | 108.03M | 124.21M | 79.42M | 23.02M |
| Account Payables | 648.00K | 1.46M | 1.08M | 537.00K | 198.00K |
| Deferred Revenue | 1.21M | n/a | n/a | 2.72M | 179.00K |
| Short-Term Debt | 5.62M | 2.01M | n/a | 1.36M | n/a |
| Other Current Liabilities | 1.73M | 1.34M | 1.56M | 695.00K | 3.12M |
| Total Current Liabilities | 7.99M | 4.82M | 2.64M | 5.31M | 3.50M |
| Long-Term Debt | 24.48M | 29.21M | n/a | 2.41M | 115.50M |
| Other Long-Term Liabilities | n/a | n/a | n/a | 185.03M | 655.00K |
| Total Long-Term Liabilities | 24.48M | 29.21M | n/a | 187.45M | 116.16M |
| Total Liabilities | 32.47M | 34.02M | 2.64M | 192.75M | 119.66M |
| Total Debt | 30.10M | 30.21M | n/a | 3.77M | 115.50M |
| Common Stock | 5.00K | 5.00K | 5.00K | 664.00K | 664.00K |
| Retained Earnings | -72.89M | -38.92M | -8.33M | -114.00M | -97.30M |
| Comprehensive Income | -12.00K | -73.00K | -124.21M | -849.03K | -780.16K |
| Shareholders Equity | 12.87M | 36.85M | 47.41M | -113.34M | -96.64M |
| Total Investments | 42.67M | 71.47M | n/a | n/a | 1.63M |